Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7639031Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.7M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#4,225
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Charles H. Spruck as a PI. Multi-PI records show the full award amount for context.
- 5R01CA286431-03R01Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer$809.2Kaward amount
- 5R01CA267103-05R01Targeting the FBXO44/SUV39H1 Pathway in Cancer$446.1Kaward amount
- 5R01CA269339-05R01Targeting ER+ Breast Cancer Through Induced Viral Mimicry$446.1Kaward amount
Award organization
Organizations that administered FY2026 awards listing Charles H. Spruck as a PI.
FY2026 award administered by Sanford Burnham Prebys Medical Discovery Institute (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardSanford Burnham Prebys Medical Discovery Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7429
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #4225
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Charles H. Spruck.